Location History:
- Victoria, AU (2009 - 2012)
- Laveton, AU (2014)
Company Filing History:
2 out of 122 
2 out of 322 
1 out of 1 Years Active: 2009-2014
Title: Inventor Profile: Michelle A Patterson
Introduction
Michelle A Patterson is an accomplished inventor based in Victoria, Australia. With a total of three patents to her name, she has made significant strides in her field, particularly in the realm of isolated polypeptides and nucleotides. Her work is not only innovative but also plays a crucial role in advancing scientific knowledge and applications.
Latest Patents
Michelle's most recent patents focus on isolated polypeptides and nucleotides, showcasing amino acid sequences that belong to a select group identified by various SEQ ID numbers. These sequences include, but are not limited to, SEQ. ID. NO. 110, SEQ. ID. NO. 111, SEQ. ID. NO. 112, SEQ. ID. NO. 113, and additional sequences known for their biological significance. Her work exemplifies the intricate relationship between molecular biology and innovative applications.
Career Highlights
Throughout her career, Michelle has been associated with prominent organizations, including CSL Limited and The University of Melbourne. These affiliations have provided her with a robust platform to develop her inventions. Her contributions in these capacities underline her commitment to research and development in her area of expertise.
Collaborations
Michelle has had the opportunity to collaborate with talented individuals such as Bruce Carter Ross and Ian George Barr. These partnerships have likely enriched her research experiences and fostered innovative ideas, leading to her impactful inventions. Collaborations such as these are vital in the scientific community, promoting the exchange of knowledge and enhancing creativity.
Conclusion
In summary, Michelle A Patterson is a notable inventor whose work in isolated polypeptides and nucleotides continues to inspire and advance the field. Her career, marked by significant patents and collaborations, reflects her dedication to scientific advancement. As she continues to explore new horizons in her research, the innovations she brings forth will undoubtedly contribute to the broader scientific community.